Clinical Trial Update: Study Evaluating Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine With Influenza Vaccine in Adults [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study of the 13-valent pneumococcal conjugate vaccine co-administered with an influenza vaccine in adults. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infections

Drugs mentioned

• Prevnar 13 (pneumococcal conjugate vaccine)

Snippet

Sponsor: Pfizer | Conditions: Pneumococcal Infections | Phase 3 | Status: COMPLETED | Results posted: 2012-02-17